1.30
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen stock hits 52-week low at $1.25 amid sharp decline - Investing.com India
iSpecimen stock hits 52-week low at $1.25 amid sharp decline By Investing.com - Investing.com South Africa
iSpecimen appoints new accounting firm after resignation By Investing.com - Investing.com South Africa
iSpecimen appoints new accounting firm after resignation - Investing.com India
Benign Growth For iSpecimen Inc. (NASDAQ:ISPC) Underpins Stock's 26% Plummet - Simply Wall St
iSpecimen stock hits 52-week low at $1.54 amid sharp decline - Investing.com Australia
iSpecimen stock hits 52-week low at $1.54 amid sharp decline By Investing.com - Investing.com South Africa
iSpecimen Inc. Announces Leadership and Board Restructuring - Defense World
iSpecimen Announces Key Leadership Appointments - TipRanks
iSpecimen announces leadership changes, appoints new president By Investing.com - Investing.com South Africa
iSpecimen announces leadership changes, appoints new president - Investing.com India
Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews
iSpecimen stock hits 52-week low at $1.75 amid market challenges - Investing.com Nigeria
iSpecimen Stock Hits 52-Week Low at $1.81 Amid Market Challenges - MSN
iSpecimen Stock Hits 52-Week Low at $1.81 Amid Market Challenges By Investing.com - Investing.com South Africa
iSpecimen stock hits 52-week low at $1.96 amid market challenges - MSN
Certain Warrants of iSpecimen Inc. are subject to a Lock-Up Agreement Ending on 30-JAN-2025. - Marketscreener.com
iSpecimen Stock Hits 52-Week Low at $2.25 Amid Market Challenges - Investing.com Australia
The Secret to Sustainable Healthcare Innovation. Discover How Emerging Tech is Changing the Game. - MotoPaddock
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
US Stock Likely To Open Higher Ahead of Trump's Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst - Benzinga
US Stocks Likely To Open Higher Ahead of Trump's Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst - Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Benzinga
Stock Region Penny Picks - substack.com
iSpecimen Shares Rise After Securring Virus Suppliers - MarketWatch
ISpecimen Secures Suppliers for COVID-style hMPV Outbreak -January 16, 2025 at 04:02 pm EST - Marketscreener.com
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak - Newsfile
iSpecimen Secures Critical hMPV Virus Specimens as China Reports Surge in Cases - StockTitan
ISPC Stock: The Next Tech Breakthrough? Discover the Future of Investing! - MotoPaddock
Waters Corporation (WAT) Stock Surges Amid Strong Financial Perf - GuruFocus.com
iSpecimen stock hits 52-week low at $2.6 amid market challenges - Investing.com
Scientists just excavated an unprecedented specimen from Antarctica - Mashable
AWH Stock Surges Over 5% Amid Mixed Analyst Ratings - GuruFocus.com
iSpecimen Inc. (NASDAQ:ISPC) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough - Simply Wall St
ISpecimen Inc. Appoints Yuying Liang as Chief Financial Officer - Marketscreener.com
ISpecimen Will Serve as a Preferred Provider of Cancer Biospecimens - Marketscreener.com
iSpecimen stock hits 52-week low at $2.75 amid market challenges - Investing.com
iSpecimen Strengthens Leadership and Expands Cancer Research Focus - TipRanks
iSpecimen expands cancer biospecimen services for research - Investing.com
iSpecimen Unveils Major Cancer Biospecimen Initiative, Partners with Leading Genomics Lab for 2025 Growth - StockTitan
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
ISpecimen Inc. Appoints Robert Bradley Lim as Chief Executive Officer - Marketscreener.com
ISpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers - Marketscreener.com
Cal-Maine Foods IN (CALM-Q) QuotePress Release - The Globe and Mail
iSpecimen appoints Robert Lim as CEO - MSN
Pre-market Movers: LOOP, RPTX, CADL, INO, ISPC… - RTTNews
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):